0001974158-24-000041.txt : 20240528
0001974158-24-000041.hdr.sgml : 20240528
20240528174541
ACCESSION NUMBER: 0001974158-24-000041
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20240528
DATE AS OF CHANGE: 20240528
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Enliven Therapeutics, Inc.
CENTRAL INDEX KEY: 0001672619
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 811523849
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-39247
FILM NUMBER: 24993299
BUSINESS ADDRESS:
STREET 1: 6200 LOOKOUT ROAD
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: 720-647-8519
MAIL ADDRESS:
STREET 1: 6200 LOOKOUT ROAD
CITY: BOULDER
STATE: CO
ZIP: 80301
FORMER COMPANY:
FORMER CONFORMED NAME: IMARA Inc.
DATE OF NAME CHANGE: 20160419
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Hohl Benjamin
CENTRAL INDEX KEY: 0001882764
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: 6200 LOOKOUT ROAD
CITY: BOULDER
STATE: CO
ZIP: 80301
144
1
primary_doc.xml
144
0001882764
XXXXXXXX
LIVE
0001672619
Enliven Therapeutics, Inc.
001-39247
6200 LOOKOUT ROAD
BOULDER
CO
80301
720-647-8519
Hohl Benjamin
Officer
Common
Jefferies LLC
520 Madison Ave
4th Fl
New York
NY
10022
4250
101745.00
47000000
05/28/2024
NASDAQ
Common
08/09/2022
Stock Options Grant
Enliven Therapeutics
N
4250
08/09/2022
N/A
N
Benjamin Hohl
6200 Lookout Rd 1st FL
Boulder
CO
80301
Enliven Therapeutics
05/03/2024
1000
22396.32
Benjamin Hohl
6200 Lookout Rd 1st FL
Boulder
CO
80301
Enliven Therapeutics
04/29/2024
3250
55060.45
Benjamin Hohl
6200 Lookout Rd 1st FL
Boulder
CO
80301
Enliven Therapeutics
04/11/2024
7000
170078.12
Benjamin Hohl
6200 Lookout Rd 1st FL
Boulder
CO
80301
Enliven Therapeutics
04/11/2024
7000
175784.07
Benjamin Hohl
6200 Lookout Rd 1st FL
Boulder
CO
80301
Enliven Therapeutics
03/27/2024
3250
59198.35
Benjamin Hohl
6200 Lookout Rd 1st FL
Boulder
CO
80301
Enliven Therapeutics
02/27/2024
3250
55058.79
All Sales are to be made pursuant to a previously signed/adopted 10b5-1 Selling plan dated 06/26/2023, and all representations regarding material non-public information were made as of the adoption of the plan.
05/28/2024
06/26/2023
Benjamin Hohl